Lipid Metabolism Disorder: Clinical Trials

14 trials for Lipid Metabolism Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 10 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 6, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Lipid Metabolism Disorder: new trials by email Literature Review of Lipid Metabolism Disorder trials Research Report on Lipid Metabolism Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients
Taohong Tongluo Xiaoban Prescription, Fundamental medical treatment - Cerebral Infarction, Chinese Herbal Medicine
Not applicableNot yet recruitingYan Zhu1602024-10-012024-08-14
Preventing Exercise Resistance With Sedentary Interruptions
Standing interruptions, Exercise bout, Sedentary - Sedentary Behavior, Lipid Metabolism Disorder
Not applicableUnknownHasselt University242024-02-192024-03-04
Health Effects of Biostimulated Lettuce in Human
Control Group, Biostimulated group - Nutrition, Healthy, Dietary Deficiency
Not applicableCompletedUniversity of Palermo1002023-03-012023-08-02
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Implementation Strategy Bundle, Usual care notification - Lipid Metabolism Disorder
Not applicableRecruitingUniversity of Texas Southwestern Medical Center1002023-02-272026-03-17
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.
Obicetrapib, Placebo - Dyslipidemias, High Cholesterol
Phase 3CompletedNewAmsterdam Pharma3542022-07-252025-06-11
Impact of Foods on Bile Acids, Metabolites, and Inflammation
Lentil, Control - Inflammation, Hypertriglyceridemia
Not applicableUnknownMontana State University242022-02-242023-05-06
Improvement of Nutritional Status and Blood Lipid Profile by Using MCT Oil on Overweight and Obese Women
Soya bean oil, MCT oil - Obesity Adult Onset, Lipid Metabolism Disorder
Not applicableCompletedNational Institute of Nutrition, Vietnam1612019-09-082020-09-10
Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus
omega-3 polyunsaturated fatty acids, corn oil - Type 2 Diabetes Mellitus, Lipid Metabolism Disorder
Not applicableCompletedSoutheast University, China1102019-06-082023-11-27
Possible Links Between Inflammation and Lipid Metabolism
LPS infusion - Sepsis, Inflammation
Not applicableCompletedBarmherzige Brüder Linz102017-12-202018-10-17
Almond Consumption and Glycemia
Almonds, Control (no nuts) - Glucose Intolerance, Appetite Disorders
Not applicableCompletedPurdue University752017-08-012021-01-07
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
XueZhiKang, Lovastatin - Lipid Metabolism Disorder
Phase 1CompletedLuye Pharma Group Ltd.202015-11-012016-12-05
Effect of a Carbohydrate-rich Diet in Healthy Subjects
isocaloric diet, Hypercaloric diet, Liquid meal - Lipid Metabolism Disorder
Not applicableCompletedUniversité de Sherbrooke142013-04-102019-09-12
Lipid Management in Clinical Practice (MK-0524A-115)
Lipid Metabolism Disorder
CompletedMerck Sharp & Dohme LLC23902009-10-012015-08-11
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
ezetimibe - Lipid Metabolism Disorder
Phase 4CompletedOrganon and Co802004-09-012024-08-15

Narrower conditions

Lipid Metabolism Disorders (14)  ·  Glucose Metabolism Disorders (2)  ·  Hypercholesterolemia (2)  ·  Inflammation (2)  ·  Metabolic Diseases (2)  ·  Bone Resorption (1)  ·  Cerebral Infarction (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dyslipidemias (1)  ·  Fatty Liver (1)  ·  Feeding and Eating Disorders (1)  ·  Genetic Diseases, Inborn (1)  ·  Glucose Intolerance (1)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemia Type II (1)

Broader conditions

Nutritional and Metabolic Diseases (14)  ·  Metabolic Diseases (12)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (3)  ·  Dyslipidemias (2)  ·  Hyperlipidemias (2)  ·  Nutrition Disorders (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Body Weight (1)  ·  Bone Diseases (1)  ·  Brain Diseases (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)

Interventions

Calorimetry, Indirect (1)  ·  Control Groups (1)  ·  Corn Oil (1)  ·  Docosahexaenoic Acids (1)  ·  Ezetimibe (1)  ·  Lovastatin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Soybean Oil (1)  ·  lentil lectin (1)  ·  xuezhikang (1)

Sponsors

Barmherzige Brüder Linz (1)  ·  Hasselt University (1)  ·  Luye Pharma Group Ltd. (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Montana State University (1)  ·  National Institute of Nutrition, Vietnam (1)  ·  NewAmsterdam Pharma (1)  ·  Organon and Co (1)  ·  Purdue University (1)  ·  Southeast University, China (1)  ·  University of Palermo (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Université de Sherbrooke (1)  ·  Yan Zhu (1)

Countries

United States (5)  ·  Canada (2)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  Czechia (1)  ·  Georgia (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  Vietnam (1)

Top investigators

Amit Khera, MD (1)  ·  Marc Ditmarsch (1)  ·  Mary P Miles, PhD (1)  ·  Matthias Heinzl, MD (1)  ·  Richard D Mattes, PhD (1)  ·  Sara Baldassano Professor, PhD (1)  ·  Simon LI, M.D. (1)  ·  Tu S Nguyen, PhD. (1)

Results publications

PMID 18845704, PMID 31843964, PMID 33870714, PMID 34273987, PMID 35616594, PMID 38705341, PMID 41760952, PMID 42400437

NIH funding

R61HL161753 (1)